Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05464654Not ApplicableCompleted

Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause

Role: lead

NCT05372224Not ApplicableCompleted

Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis

Role: lead

NCT05346445Not ApplicableCompleted

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Role: lead

NCT05347082Not ApplicableCompleted

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

Role: lead

NCT05346419Not ApplicableCompleted

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

Role: lead

All 5 trials loaded